| Multisystem inflammatory syndrome in US children and adolescents LR Feldstein, EB Rose, SM Horwitz, JP Collins, MM Newhams, MBF Son, ... New England Journal of Medicine 383 (4), 334-346, 2020 | 2830 | 2020 |
| Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19 LR Feldstein, MW Tenforde, KG Friedman, M Newhams, EB Rose, ... Jama 325 (11), 1074-1087, 2021 | 885 | 2021 |
| The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee E Campo, ES Jaffe, JR Cook, L Quintanilla-Martinez, SH Swerdlow, ... Blood, The Journal of the American Society of Hematology 140 (11), 1229-1253, 2022 | 841 | 2022 |
| Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy B Coiffier, B Pro, HM Prince, F Foss, L Sokol, M Greenwood, D Caballero, ... Journal of Clinical Oncology 30 (6), 631-636, 2012 | 754 | 2012 |
| Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial S Horwitz, OA O'Connor, B Pro, T Illidge, M Fanale, R Advani, NL Bartlett, ... The Lancet 393 (10168), 229-240, 2019 | 716 | 2019 |
| Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study OA O'Connor, B Pro, L Pinter-Brown, N Bartlett, L Popplewell, B Coiffier, ... Journal of Clinical Oncology 29 (9), 1182-1189, 2011 | 710 | 2011 |
| Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United … EA Olsen, S Whittaker, YH Kim, M Duvic, HM Prince, SR Lessin, GS Wood, ... Journal of Clinical Oncology 29 (18), 2598-2607, 2011 | 683 | 2011 |
| Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial HM Prince, YH Kim, SM Horwitz, R Dummer, J Scarisbrick, P Quaglino, ... The Lancet 390 (10094), 555-566, 2017 | 569 | 2017 |
| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 562 | 2018 |
| Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: results of the pivotal phase II BELIEF (CLN-19) study OA O'Connor, S Horwitz, T Masszi, A Van Hoof, P Brown, J Doorduijn, ... Journal of Clinical Oncology 33 (23), 2492-2499, 2015 | 515 | 2015 |
| Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers SI Jawed, PL Myskowski, S Horwitz, A Moskowitz, C Querfeld Journal of the American Academy of Dermatology 70 (2), 205. e1-205. e16, 2014 | 509 | 2014 |
| Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic … OA O'Connor, ML Heaney, L Schwartz, S Richardson, R Willim, ... Journal of Clinical Oncology 24 (1), 166-173, 2006 | 483 | 2006 |
| EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary … W Kempf, K Pfaltz, MH Vermeer, A Cozzio, PL Ortiz-Romero, M Bagot, ... Blood, The Journal of the American Society of Hematology 118 (15), 4024-4035, 2011 | 482 | 2011 |
| Complete surgical excision is essential for the management of patients with breast implant–associated anaplastic large-cell lymphoma MW Clemens, LJ Medeiros, CE Butler, KK Hunt, MA Fanale, S Horwitz, ... Journal of Clinical Oncology 34 (2), 160-168, 2016 | 475 | 2016 |
| A targeted mutational landscape of angioimmunoblastic T-cell lymphoma O Odejide, O Weigert, AA Lane, D Toscano, MA Lunning, N Kopp, S Kim, ... Blood, The Journal of the American Society of Hematology 123 (9), 1293-1296, 2014 | 444 | 2014 |
| Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766-3773, 2015 | 438 | 2015 |
| Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome KL LaRovere, BJ Riggs, TY Poussaint, CC Young, MM Newhams, ... JAMA neurology 78 (5), 536-547, 2021 | 399 | 2021 |
| Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma CH Moskowitz, H Schöder, J Teruya-Feldstein, C Sima, A Iasonos, ... Journal of clinical oncology 28 (11), 1896-1903, 2010 | 394 | 2010 |
| Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2 AB Payne, Z Gilani, S Godfred-Cato, ED Belay, LR Feldstein, MM Patel, ... JAMA network open 4 (6), e2116420-e2116420, 2021 | 390 | 2021 |
| Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin SM Horwitz, RH Advani, NL Bartlett, ED Jacobsen, JP Sharman, ... Blood, The Journal of the American Society of Hematology 123 (20), 3095-3100, 2014 | 375 | 2014 |